Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe study record history now shows that the trial is no longer recruiting participants, and the record has been updated to revision 3.6.0.SummaryDifference0.4%

- Check15 days agoChange DetectedA new revision entry, v3.5.5, appears in the record history. The previous revision, v3.5.4, is removed from the visible list.SummaryDifference0.1%

- Check29 days agoChange DetectedA new platform revision entry (v3.5.4) was added to the page history, signaling an update to the underlying UI, while the previous revision label (v3.5.3) was removed from the list.SummaryDifference0.1%

- Check51 days agoChange DetectedA new revision label v3.5.3 was added to the history, and the older v3.5.2 was removed. This reflects an administrative update to the page's revision history rather than substantive content changes.SummaryDifference0.1%

- Check58 days agoChange DetectedThe Record History page reflects a new version submission date and an updated “Revision” identifier, along with the latest “Study Status” update entry in the version list.SummaryDifference0.5%

- Check87 days agoChange DetectedThe study's revision history now includes a new entry for v3.5.0 and removes the v3.4.3 entry. This updates the version history display without changing the underlying study data.SummaryDifference0.1%

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.